Curis, Inc. (CRIS)
0.4992
-0.01
(-2.75%)
USD |
NASDAQ |
May 15, 14:28
Curis EPS Diluted (Quarterly) : -1.250 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -1.03 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | 1.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.20M |
| Total Expenses (Quarterly) | 24.20M |
| Enterprise Value | 6.344M |
| Earnings Yield | -239.2% |
| Normalized Earnings Yield | -388.90 |